HLS Therapeutics GAAP EPS of -$0.12, revenue of $13.5M
2025-11-13 10:13:18 ET
More on HLS Therapeutics
- HLS Therapeutics announces new credit agreement
- Seeking Alpha’s Quant Rating on HLS Therapeutics
- Historical earnings data for HLS Therapeutics
- Financial information for HLS Therapeutics
Read the full article on Seeking Alpha
For further details see:
HLS Therapeutics GAAP EPS of -$0.12, revenue of $13.5MNASDAQ: HLTRF
HLTRF Trading
0.0% G/L:
$3.44 Last:
100 Volume:
$3.44 Open:



